|
Stephen F. Keane brings to Ambit more than 20 years of experience in the biotechnology industry, during which he has negotiated numerous strategic corporate alliances, established joint ventures and assisted in public and private financings to support product development. Prior to joining Ambit, Keane held senior corporate development positions with Dendreon Corporation, Corvas International, Epimmune Inc., SIBIA Neurosciences, Inc. and Molecular Biosystems, Inc. In these positions, he was responsible for negotiating significant alliances including licenses, distributions agreements, technology acquisitions and research agreements with large pharmaceutical companies and government agencies. He served as the principal negotiator for the acquisition of Corvas by Dendreon and SIBIA by Merck & Co. Keane received a B.A. from San Diego State University. | 